Elanco options put demand spikes as retail attention rises

Options traders loaded up on downside protection in Elanco Animal Health on Tuesday. The put-call ratio jumped to 0.56, a reading 4.2 standard deviations above its 20-day mean of 0.37. Earnings land on November 6.

The PCR had sat in a narrow band around 0.37 for most of October. Tuesday's reading marks the sharpest single-session move in the trailing 30 days. That shift arrives two days after Jefferies downgraded the stock to Hold from Buy and cut its price target 22.6%, from $31 to $24.

Analyst split deepens

The Jefferies cut sits in direct tension with the Goldman Sachs initiation just four days earlier. Goldman opened coverage with a Buy and a $32 target on October 16. The consensus still reads Buy, with nine outright Buy ratings and three Holds, and a mean price target of $30.31, roughly 34% above Wednesday's close of $22.55.

That gap between the price and the consensus target reflects how far the stock has drifted. The Jefferies downgrade follows a pattern the bear case has been making for some time: generic pressure, antibiotic-regulation risk, and the concern that pricing is doing more work than volume.

Retail attention surges

Wikipedia views and ORTEX page traffic for Elanco are running 2.56 standard deviations above their own 90-day average as of October 22. That is an attention reading, not a revenue or earnings indicator, but the timing alongside the options move and the analyst action means more eyes are on this name than usual ahead of the print.

Short interest in context

Short interest stands at 7.4% of free float, up roughly 22% over the past month. That build is meaningful. The lending market, however, is not tight. Availability sits at 597%, meaning nearly six shares remain available to borrow for every one already lent out, well within a loose borrow environment. The cost to borrow is 0.56%, up about 9% on the week but still low in absolute terms.

Data summary

• Put-call ratio: 0.56 on October 21, z-score 4.2 vs. 20-day mean of 0.37
• Jefferies: downgraded to Hold, target cut to $24 from $31 (October 20)
• Goldman Sachs: initiated Buy, $32 target (October 16); consensus Buy, mean target $30.31
• Short interest: 7.4% of free float, up 22% over 30 days
• Availability: 597%, borrow market loose; cost to borrow 0.56%
• Retail attention: 2.56 standard deviations above 90-day average (Wikipedia/ORTEX traffic)
• Next earnings: November 6